Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

An in vitro study suggests an improved safety profile for BAY-50-4798 in HIV patients

Feb. 19, 2004

Clinically meaningful antiviral effects of TNX-355 in HIV-infected patients

Feb. 19, 2004

K5-N,OS(H), a potential topical microbicide for HIV transmission prevention

Feb. 19, 2004

tgAAC-09 enters new clinical trial for prevention of AIDS

Feb. 19, 2004

Combination of chemokine antagonists for HIV-1 therapy

Feb. 19, 2004

KRH-2731: A novel chemokine antagonist for HIV-1 therapy

Feb. 19, 2004

Strong antiviral effects of Sch-D monotherapy in HIV-infected patients

Feb. 18, 2004

Good pharmacokinetic profile found for IL-4/13 Trap in healthy volunteers

Feb. 18, 2004

Strong suppression of HBV replication found with emtricitabine in HIV-positive patients

Feb. 18, 2004

In vitro metabolism and pharmacokinetics of the maturation inhibitor PA-457

Feb. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...